CKII, formerly known as casein kinase II, is a serine͞threonine kinase that is ubiquitously expressed in different cell types and organisms (1, 2) . It appears to signal through a second messenger-independent pathway and functions as a key regulatory enzyme in cell growth and differentiation (2, 3) . The enzyme is found in both the nucleus and cytoplasm with the majority found in the nucleus. Purified CKII holoenzyme is a heterotetramer with CKII␣ or CKII␣Ј (an isoform of ␣) as the catalytic subunit and CKII␤ as the noncatalytic subunit. The ␤ subunit of CKII can interact with another ␤ subunit and link two ␣ subunits together to form an ␣ 2 ␤ 2 heterotetramer (4). The functional role of the ␤ subunit is not clear. Studies in Schizosaccharomyces pombe have revealed that overexpression of Ckb1 (gene encoding CKII␤) induces multiple septation and inhibits cell growth and cytokinesis without significantly affecting CKII kinase activity (5) . Disruption of the Ckb1 ϩ gene in fission yeast results in a cold-sensitive phenotype and abnormal cell shape (5) . In mammalian fibroblasts, microinjection of an anti-CKII␤ antibody inhibits the mitogenstimulated G 1 to S transition, suggesting that this enzyme might be important for the mitotic cell cycle (6) .
In addition to CKII␣, CKII␤ binds to another serine͞ threonine kinase, Mos (7) . Mos is specifically expressed in germ cells and is required for normal Xenopus oocyte maturation (8) . Fully grown Xenopus oocytes (stage VI) are arrested at the prophase of meiosis I, and they contain maternal mos mRNA but little Mos protein (9) . Progesterone secreted from the surrounding follicle cells releases oocytes from the prophase arrest. As a result, oocytes undergo a series of events called maturation: germinal vesicle breakdown (GVBD), extrusion of the first polar body, progression into meiosis II, and metaphase arrest as unfertilized eggs (10) . Mos protein is synthesized in response to progesterone, reaches its peak shortly after GVBD, and is degraded upon fertilization (8) . Despite its transient appearance, Mos protein is necessary and sufficient to initiate meiosis and is essential for the metaphase arrest in meiosis II (9, 11, 12) . These biological functions of Mos can be explained by its ability to stimulate a mitogenactivated protein kinase (MAPK) by phosphorylating and activating a MAPK kinase, MKK (13, 14) . Like Mos, constitutively active forms of MKK and MAPK are able to induce GVBD in Xenopus oocytes and cause metaphase arrest in Xenopus embryos (15) (16) (17) . The initial activation of MAPK coincides with the activation of a maturation promoting factor (MPF), which serves as an M phase regulator and drives meiotic progression (18, 19) . A positive feedback loop has been demonstrated that connects Mos protein synthesis, MAPK activation, and MPF activation (20) (21) (22) .
The finding that endogenous CKII␤ binds to Mos in Xenopus egg extracts is intriguing because the binding of CKII␤ to Mos represses Mos-mediated MKK and MAPK activation in vitro (7) . Ectopic expression of CKII␤ in Xenopus oocytes inhibits progesterone-induced maturation likely because it binds to Mos and inhibits Mos-dependent MAPK activation (7). However, it was not clear whether the function of endogenous CKII␤ was to restrict Mos activity. Here we report that the injection of CKII␤ antisense oligonucleotide reduced the endogenous CKII␤ protein level and stimulated Mosdependent activation of MAPK, MPF, and GVBD in Xenopus oocytes treated with low concentrations of progesterone. We propose that the endogenous CKII␤ normally sets a threshold level for Mos protein, which must be exceeded for Mos to activate the MAPK signaling pathway and induce oocyte maturation.
MATERIALS AND METHODS
Oligonucleotides, RNA, and glutathione S-transferase (GST) Fusion Proteins. The antisense and sense oligonucleotides were designed against the coding region of Xenopus CKII␤ cDNA (residues 175 to 182) (23) . The sequence of the antisense oligonucleotide is 5Ј-GATTGGCAGGCCTCTT-GGGCC-3Ј and that of the sense oligonucleotide is 5Ј-GGCCCAAGAGGCCTGCCAATC-3Ј. The three phosphodiester links at the 3Ј end of each oligonucleotide were replaced by phosphorothioate links (24) . Myc-tagged CKII␤ (human) mRNA was in vitro transcribed using SP6 RNA polymerase (7) . GST and GST-CKII␤ 141-215 proteins were purified from E. coli as described (7) .
Microinjection and GVBD Assays in Xenopus Oocytes. Stage VI oocytes were isolated from female Xenopus ovaries using collagenase and cultured in L-15 medium (25) . About 30 nl of 2 mg͞ml antisense or sense oligonucleotide was microinjected into each oocyte followed by incubation at 18°C overnight before the addition of progesterone. In some experiments 1 mg͞ml Myc-CKII␤ RNA was coinjected with the oligonucleotides. In the rescue experiment, 30-40 nl of 3 mg͞ml GST or GST-CKII␤ 141-215 protein was microinjected into each oocyte 12 h after the oligonucleotide injection. The injected oocytes were subsequently treated with progesterone. Twenty to thirty oocytes were used for each analysis. GVBD was scored 8-12 h after the addition of progesterone by the appearance of a white spot on the animal pole, and subsequently it was confirmed by dissection. Oocyte extracts were prepared as described (7).
Immunoblotting and Kinase Assays. Anti-p42MAPK (Xenopus) antibody 1913.3 (1:10,000 dilution), anti-phospho-MAPK antibody (NEB, 1:1,000), anti-CKII␤ (human, 1:2,000) antibody, and anti-Mos (Xenopus K2, 1:1,000) antibodies were used respectively for immunoblotting. 9E10 hybridoma supernatant was used for immunoblotting Myc-tagged proteins (7). MAPK and MPF activities were assayed by the radiolabeled phosphate incorporation into myelin basic protein and histone H1, respectively. Extracts equivalent to half an oocyte were used for each kinase assay. The kinase reactions were performed in a 25-l kinase buffer (10 mM MgCl 2 ͞10 mM Tris, pH 7.5͞5 M protein kinase A inhibitor͞1 mM phenylmethysulfonyl fluoride͞1 mM aprotinin͞0.5 mM Na 3 VO 4 ) containing 100 M ATP (1,000 cpm͞pmol) and 1.6 mg͞ml myelin basic protein or histone H1 (Sigma). The reaction mix was incubated at 25°C for 15 min and resolved on SDS͞PAGE.
RESULTS

Reduction of CKII␤ Protein Level in Xenopus
Oocytes. The protein level of CKII␤ was almost the same in extracts of Xenopus oocytes and eggs (Fig. 1A Upper) . To reduce the amount of CKII␤, we microinjected antisense oligonucleotides into stage VI oocytes. The 21-mer oligonucleotides were modified in linkages at the 3Ј end to increase stability (24) . A control, sense oligonucleotide had little effect on CKII␤ protein level in oocytes. By contrast, an antisense oligonucleotide significantly decreased the endogenous CII␤ protein by 30-40% ( Fig. 1 A Upper) . Importantly, the antisense oligonucleotides did not affect the amounts of other proteins such as p42 MAPK ( Fig. 1 A Lower) . We consistently observed two bands that ran at a position similar to the control CKII in CKII␤ immunoblot ( Fig. 1 A Upper) . It was not clear whether they were due to protein degradation, or phosphorylation, or a yet to be identified CKII␤ gene product. The CKII␤ anti- sense oligonucleotide was not only effective on the endogenous CKII␤ protein but also on an ectopically expressed Myc-tagged CKII␤. When Myc-CKII␤ RNA was coinjected with antisense CKII␤ oligonucleotide into oocytes, the accumulation of Myc-CKII␤ protein was reduced by 35-40% (Fig.  1B) .
Stimulation of GVBD in Oocytes with a Reduced Level of CKII␤ Protein. During meiotic maturation, one hallmark of a mature Xenopus oocyte is the formation of a white spot on the animal pole after GVBD. We studied the effects of CKII␤ sense and antisense oligonucleotides on oocyte maturation by scoring the number of oocytes that underwent GVBD in response to progesterone. Oocytes injected with the CKII␤ sense oligonucleotide or another antisense oligonucleotide that failed to reduce the amount of endogenous CKII␤ protein behaved the same as the control oocytes injected with water (data not shown). By contrast, oocytes injected with the effective CKII␤ antisense oligonucleotide had increased sensitivity to progesterone: 8-to 10-fold less progesterone was needed to induce 50% GVBD by 8 h compared with control oocytes (Fig. 2A) . Strikingly, at a very low concentration of progesterone (5 ng͞ml), 58% of oocytes injected with the antisense oligonucleotide showed GVBD and all of them had full MAPK activity, whereas GVBD did not occur and MAPK was inactive in the control oocytes ( Fig. 2 A and B) . MPF activity, as monitored by the histone H1 kinase assay, was also strongly increased by the antisense oligonucleotide at 5 ng͞ml progesterone (Fig. 2B ). Higher progesterone concentration could overcome the effect of the antisense oligonucleotide (Fig. 2, 50 ng͞ml progesterone) . This is likely due to an elevated Mos protein level in response to increased progesterone (Fig. 2B , Anti-Mos). Interestingly, much less Mos protein was accumulated in the control oocytes than in the antisense oligonucleotide injected oocytes, when 5 ng͞ml progesterone was used (Fig. 2B) . This is consistent with the hypothesis that there is positive feedback from activated MAPK and MPF to Mos protein synthesis or accumulation (20) (21) (22) , although we cannot rule out the possibility that CKII␤ might reduce Mos protein stability.
The Acceleration of MAPK Activation and GVBD by CKII␤ Antisense Oligonucleotide. Since Mos-dependent MAPK activation is essential for GVBD (15, 26) , we examined the time course of MAPK phosphorylation during meiotic maturation. In the presence of 5 ng͞ml progesterone, MAPK bandshift was detected by 30 min and completed by 5 h in oocytes injected with the antisense oligonucleotide, whereas MAPK was completely inactive in the control oocytes even after 6 h (Fig. 3A  Top) . A higher concentration of progesterone (25 ng͞ml) allowed MAPK phosphorylation to be first detected in control oocytes at 2.5 h. Under the same conditions, antisense oligonucleotide-injected oocytes showed detectable MAPK phosphorylation at the first 30 min, and the phosphorylation reached 70% by 2.5 h (Fig. 3A Middle) . Bandshifts of MAPK correlated well with the phosphorylation of MAPK as assayed by phospho-MAPK immunoblotting (Fig. 3A Bottom) . Furthermore, GVBD was accelerated in the CKII␤ antisense oligonucleotide-injected oocytes (Fig. 3B) . After 2 h of progesterone treatment (50 ng͞ml), more than 50% of oocytes exhibited GVBD, and by 3.5 h, 100% of oocytes completed GVBD. In contrast, only 26% of oocytes injected with sense oligonucleotide underwent GVBD within 3 h of progesterone stimulation, and even after 7 h, only 80% of them showed GVBD (Fig. 3B) . These results suggest that lowering the concentration of CKII␤ not only sensitizes oocytes to low progesterone concentrations, but also accelerates the maturation process.
The Rescue of CKII␤ Antisense Oligonucleotide Effects by GST-CKII␤ 141-215 . Ectopic expression of CKII␤ in Xenopus oocytes inhibits progesterone-induced oocyte maturation likely by the binding of CKII␤ to Mos and repression of Mos-mediated MAPK activation (7) . A fragment of CKII␤ that does not bind to Mos, CKII␤ , had no effect (7) . If the effect of CKII␤ antisense oligonucleotide on oocyte maturation was due to the reduction in endogenous CKII␤ protein level, we reasoned that ectopic expression of CKII␤ should be able to rescue the phenotype. For this purpose, we first microinjected sense or antisense oligonucleotide and then injected a GST fusion protein containing the C-terminal 75 amino acids of CKII␤, GST-CKII␤ 141-215 , which has a higher affinity than full-length GST-CKII␤ for binding to Mos (7) . As a control for the fusion protein, some oocytes were injected with GST. When challenged with 25 ng͞ml progesterone, 53% of oocytes injected with antisense oligonucleotide followed by GST underwent GVBD, compared with 33% of oocytes injected with antisense oligonucleotide followed by GST-CKII␤ . By contrast, 23% of oocytes injected with sense oligonucleotide and GST underwent GVBD (Fig. 4A Left) . When a higher concentration of progesterone (50 ng͞ml) was used, more control oocytes completed GVBD and the antisense effect was less pronounced, but GST-CKII␤ 141-215 again inhibited GVBD (Fig. 4A Right) . MAPK phosphorylation in both antisense and sense oligonucleotide-injected oocytes was inhibited by GST-CKII␤ (Fig. 4B) . Because the ectopic expression of CKII␤ fusion protein can rescue the phenotype of the CKII␤ antisense oligonucleotide, we conclude that the effects of the CKII␤ antisense oligonucleotide on progester- 
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DISCUSSION
CKII␤ is likely to be a physiological repressor of Mos based on the following evidence. First, CKII␤ binds to Mos and represses Mos-dependent MAPK phosphorylation both in vivo and in vitro (7) . Second, ectopic expression of CKII␤ in Xenopus oocytes inhibits progesterone-induced, Mosdependent MAPK phosphorylation and oocyte maturation (7). Third, endogenous CKII␤ is bound to Mos synthesized from stored mRNA during oocyte maturation (7) . Moreover, as we report here, whereas Mos protein level increases during Xenopus oocyte maturation, the amount of CKII␤ protein remains almost the same. Reducing the endogenous CKII␤ protein level by using an antisense oligonucleotide increases the activities of MAPK and MPF, increases Mos protein levels, and promotes GVBD in oocytes treated with a low concentration of progesterone. At a higher progesterone concentration, reducing the content of CKII␤ accelerates MAPK phosphorylation and GVBD. These effects are specific and can be overruled by injecting oocytes with a C-terminal fragment of CKII␤ that binds to Mos and artificially restores the in vivo CKII␤ protein level.
Based on these results, we propose a threshold model to explain the endogenous function of CKII␤. As shown in Fig.  5 , upon progesterone treatment of oocytes, the initially synthesized Mos protein associates with CKII␤ and remains inactive (step 1). As meiotic maturation progresses, the amount of Mos protein reaches and then exceeds the threshold level determined by CKII␤ (step 2). Excess Mos molecules phosphorylate and activate MKK, which in turn activates MAPK. At this time a positive feedback loop involving MAPK activation, MPF activation, and Mos protein synthesis is established (20) (21) (22) , which leads to GVBD (step 3). Ectopic expression of CKII␤ increases the threshold level of Mos and inhibits progesterone-induced, Mos-dependent MAPK activation and GVBD. By contrast, a decrease in the threshold level by lowering the concentration of CKII␤ means that less Mos protein is needed to initiate meiosis and oocytes undergo GVBD at a low concentration of progesterone. Our results do not exclude the possibility that CKII␤ may also limit Mos protein accumulation by, for example, targeting Mos for degradation. As in the proposed model, stimulation of Mos degradation would also set a threshold level for the accumulation of Mos before GVBD can commence.
CKII␤ was originally identified as a noncatalytic subunit of CKII that binds to the catalytic subunit, CKII␣ (27, 28) . Mammalian CKII␤ has 215 residues in two separate, functional domains (3). The ␤-␤ homodimerization domain is localized between residues 20 and 145 and the ␣-␤ heterodimerization domain is localized in the C-terminal 45 amino acids (29, 30) . The C terminus of CKII␤ also binds to Mos (7). In addition, CKII␤ contains clusters of acidic amino acids at the N terminus, basic amino acids at the C terminus, four cysteines that might form a zinc finger, and a cyclin destruction box-like domain that might target the protein for degradation (3) . The stoichiometry of CKII␤ and CKII␣ is not clear in vivo; however, in several cell lines CKII␤ is synthesized more rapidly than CKII␣ and the excess is rapidly degraded (31) .
Despite much effort, the regulation of CKII activity is still poorly understood. One observation suggests that CKII␤ may be regulated during mitosis and meiosis. Using an expressioncloning strategy in HeLa S3 cells, Matsumoto-Taniura et al. (32) have found that CKII␤ is recognized by MPM2, an antibody that stains some M phase phosphorylation sites. Therefore, CKII␤ is an MPM2 antigen that is phosphorylated at M phase of the cell cycle, possibly by MAPK or another unidentified MPM2 kinase.
The regulation of Mos is achieved partially through the increased translation when stored maternal mos mRNA becomes polyadenylated (33) . In addition, serine-3 phosphorylation has been shown to be important for Mos protein stability and its interaction with the substrate MKK (25, 34) . Then what is the benefit of a stoichiometric inhibitor, CKII␤, as opposed to other restrictions on Mos quantity or phosphorylation? Biochemical analysis using Xenopus oocyte extracts has suggested that the three-kinase cascade of Mos, MKK, and MAPK allows a large change in signal output (MAPK activity) in response to a small change in signal input (Mos protein quantity) (35) . This results from cooperativity and nearsaturation ''zero-order ultrasensitivity'' (36, 37) . A stoichiometric inhibitor further increases the sensitivity of a system (37) . As the quantity of a kinase increases above the level of an inhibitor, kinase activity follows a sharp, hyperbolic stimulus-response curve to generate a switch-like output (37) . This may explain the observation that MAPK activation, MPF activation, and GVBD all occur within a narrow time window starting several hours after progesterone stimulation. Together with the positive feedback loop linking Mos protein synthesis, MAPK activation, and MPF (20) , this ensures the coordinated activation of MAPK and MPF that commits oocytes irreversibly to GVBD, chromosome condensation, suppression of DNA replication, entry into meiosis II, and the subsequent metaphase arrest.
